Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06204666 · ClinicalTrials.gov registry record · NA
Hemp Fiber Ingestion and Gut Permeability After Exercise
A NA study, sponsored by Appalachian State University.
- Completed
- Registry status
- NA
- Development phase
- 25
- Enrollment target
NCT06204666 is a NA study that has completed, run by Appalachian State University. The registered enrollment target is 25 participants.
The verdict
NCT06204666, a NA study, has completed, sponsored by Appalachian State University.
- COMPLETED
- Registry status
- NA
- Development phase
- 25 participants
- Enrollment target
Study Summary
Two bioactive compounds, N-trans-caffeoyl tyramine (NCT) and N-trans-feruloyl tyramine (NFT), have been investigated for potential gut health benefits. The shells of hemp seeds are a rich source of NCT and NFT. The hypothesis for this project is that ingestion of a hemp fiber bar containing NCT and NFT will mitigate exercise-induced increases in gut permeability. This study will examine the efficacy of 2-weeks ingestion of a hemp fiber bar (high and low doses) in moderating exercise-induced gut permeability using a randomized crossover trial. Objective #1: To conduct a randomized crossover trial using placebo-controlled, double-blind procedures with 20 cyclists who will in random order ingest a hemp fiber bar supplement (high and low doses) or placebo each day for two weeks prior to an exercise challenge (2.25 hours of intensive cycling). Objective #2: To determine if hemp fiber bar supplementation attenuates exercise-induced gut permeability using several outcome measures including plasma lactulose to 13C mannitol (L:M) ratio and plasma intestinal fatty acid binding protein (I-FABP) as markers of gastrointestinal permeability and mucosal damage, respectively. Shifts in thousands of metabolites will be measured via untargeted metabolomics to provide additional gut permeability biomarkers and help reveal underlying mechanisms.
Interventions
- DIETARY_SUPPLEMENT Placebo
- DIETARY_SUPPLEMENT High Dose Hemp Fiber Bar
- DIETARY_SUPPLEMENT Low Dose Hemp Fiber Bar
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 25 participants |
| Start Date | 2023-12-09 |
| Est. Completion | 2024-09-15 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06204666
The ClinicalTrials.gov registry entry for NCT06204666 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 25 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Appalachian State University, which has 37 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Placebo is the first listed.
NCT06204666 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06204666 about?
NCT06204666 is a clinical study titled "Hemp Fiber Ingestion and Gut Permeability After Exercise". Two bioactive compounds, N-trans-caffeoyl tyramine (NCT) and N-trans-feruloyl tyramine (NFT), have been investigated for potential gut health benefits. The shells of hemp seeds are a rich source of NCT and NFT. The hypothesis for this project is that ingestion of a hemp fiber bar containing NCT and ...
What is the current status of trial NCT06204666?
This trial is currently completed. It is a NA study. The enrollment target is 25 participants. The study started on 2023-12-09. Estimated completion is 2024-09-15.
What interventions are being tested in trial NCT06204666?
The interventions under investigation include: Placebo (DIETARY_SUPPLEMENT), High Dose Hemp Fiber Bar (DIETARY_SUPPLEMENT), Low Dose Hemp Fiber Bar (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT06204666?
This trial is sponsored by Appalachian State University, which has 37 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.